← All science articles

· 2 min read

Early Method Packages Recombinant DNA Directly Into Phage Particles

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

Hohn and Murray, writing in the Proceedings of the National Academy of Sciences in 1977, describe a laboratory method for building recombinant DNA molecules and immediately packaging them into bacteriophage particles — virus shells that infect bacteria — without needing to grow the DNA inside living cells first.

This is a molecular biology and enzymology study, done entirely with purified enzymes and viral components in a test tube (in vitro), not in animals or humans. The researchers joined DNA fragments using a ligase enzyme, formally called poly(deoxyribonucleotide):poly(deoxyribonucleotide) ligase, which stitches DNA strands together. They report that the packaging process worked efficiently and did not favor one type of DNA molecule over another, and that it offered a way to contain recombinant DNA safely during the early handling steps — a real concern in genetic engineering research at the time. One technical complication: the ligase-joined DNA could sometimes combine with the phage's own natural DNA during packaging, but the authors found that UV irradiation could destroy the biological activity of that natural DNA, cleaning up the results.

The abstract gives no further numeric detail on yields or efficiency percentages, and as a pure methods paper, it says nothing about biological or therapeutic effects of DNA fragments.

Our reflection

This paper sits far from skincare, but it is part of the deep history of nucleic-acid science that eventually made ingredients like PDRN understandable at the molecular level. Tools for handling and joining DNA fragments, developed in the 1970s, underpin decades of later work on how these molecules behave and are produced. At Havdis, we see today's PDRN research as standing on exactly this kind of foundational enzymology.

Source

Hohn B, Murray K (1977). Proceedings of the National Academy of Sciences of the United States of America.

Read the paper on PubMedDOI: 10.1073/pnas.74.8.3259Free full text (PMC)

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.